In market activity today, Knight Therapeutics Inc opened at $5.78 and closed at $5.82. prices ranged from $5.75 to $5.86.

Share prices gained 0.87% from the previous day's close of $5.77.

Today across North America, the TSX Composite closed 0.06% at 21728.55, the S&P 500 closed -0.34% at 5018.39, the Dow Jones Industrial Average closed 0.23% at 37903.29 and the Nasdaq Composite closed -0.33% at 15605.48.

Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).

A total of 23,128 shares was traded during the session, with total trades of 151, while having an average volume of 26,329 over the last 5-days.

The TSX market on the whole today saw 3,697 price advancers against 1,526 declines and 95 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.95 (April 11,2024) and low as $4.35 (October 23,2023). Moreover, the shares have boosted 26.25% in the last year, while in 2024, they have advanced 12.14%.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $583.75 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc has an average recommendation of "Moderate Buy" based on 4.00 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..